ETF constituents for IHE

Below, a list of constituents for IHE (iShares U.S. Pharmaceuticals ETF) is shown. In total, IHE consists of 39 securities.

Note: The data shown here is as of date Oct 31, 2023 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
LLY ELI LILLY Health Care Equity 146557068.0 25.93
JNJ JOHNSON & JOHNSON Health Care Equity 133115218.85 23.55
ZTS ZOETIS INC CLASS A Health Care Equity 26274912.87 4.65
MRK MERCK & CO INC Health Care Equity 26099394.5 4.62
RPRX ROYALTY PHARMA PLC CLASS A Health Care Equity 25849061.28 4.57
VTRS VIATRIS INC Health Care Equity 25056642.78 4.43
PFE PFIZER INC Health Care Equity 23965589.86 4.24
BMY BRISTOL MYERS SQUIBB Health Care Equity 22745109.4 4.02
JAZZ JAZZ PHARMACEUTICALS PLC Health Care Equity 17884711.88 3.16
CTLT CATALENT INC Health Care Equity 17605591.98 3.11
ELAN ELANCO ANIMAL HEALTH INC Health Care Equity 14624119.07 2.59
ITCI INTRA CELLULAR THERAPIES INC Health Care Equity 13061026.77 2.31
PRGO PERRIGO PLC Health Care Equity 10204252.3 1.81
OGN ORGANON Health Care Equity 7145408.1 1.26
PBH PRESTIGE CONSUMER HEALTHCARE INC Health Care Equity 7000710.2 1.24
AXSM AXSOME THERAPEUTICS INC Health Care Equity 6297148.65 1.11
CORT CORCEPT THERAPEUTICS INC Health Care Equity 5682450.55 1.01
AMPH AMPHASTAR PHARMACEUTICALS INC Health Care Equity 5130155.67 0.91
SUPN SUPERNUS PHARMACEUTICALS INC Health Care Equity 3642541.23 0.64
ARVN ARVINAS INC Health Care Equity 3231303.24 0.57
PCRX PACIRA BIOSCIENCES INC Health Care Equity 3158292.5 0.56
HRMY HARMONY BIOSCIENCES HLDG INC Health Care Equity 2418368.06 0.43
LGND LIGAND PHARMACEUTICALS INC Health Care Equity 2341800.65 0.41
USD USD CASH Cash and/or Derivatives Cash 2306139.11 0.41
COLL COLLEGIUM PHARMACEUTICAL INC Health Care Equity 2189430.0 0.39
SAVA CASSAVA SCIENCES INC Health Care Equity 2025469.75 0.36
INVA INNOVIVA INC Health Care Equity 1932539.7 0.34
PLRX PLIANT THERAPEUTICS INC Health Care Equity 1822179.6 0.32
RVNC REVANCE THERAPEUTICS INC Health Care Equity 1536008.9 0.27
AMLX AMYLYX PHARMACEUTICALS INC Health Care Equity 1291322.75 0.23
TBPH THERAVANCE BIOPHARMA INC Health Care Equity 937853.76 0.17
AVIR ATEA PHARMACEUTICALS INC Health Care Equity 545701.7 0.1
XTSLA BLK CSH FND TREASURY SL AGENCY Cash and/or Derivatives Money Market 520507.52 0.09
PAHC PHIBRO ANIMAL HEALTH CORP CLASS A Health Care Equity 488686.08 0.09
VTYX VENTYX BIOSCIENCES INC Health Care Equity 268094.9 0.05
SGAFT CASH COLLATERAL USD SGAFT Cash and/or Derivatives Cash Collateral and Margins 135000.0 0.02
ACRS ACLARIS THERAPEUTICS INC Health Care Equity 123463.75 0.02
IXCZ3 E-MINI HEALTH CARE SECTOR DEC 23 Cash and/or Derivatives Futures 0.0 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. iCRMH0323U/S-2742939 nan nan nan nan nan